drugset / Trial / NCT01048593
Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will test the efficacy and safety of IBI-10090 for the reduction of ocular inflammation after cataract surgery.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-05
- Completion
- 2010-06
Outcome
Outcome not reported
Stopped: “Study was terminated in order to examine study data.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 114 ug | Other |
| Subject | Dexamethasone | Small molecule | 513 ug | Other |
| Subject | Dexamethasone | Small molecule | 684 ug | Other |